BUZZ-Wedbush lifts Praxis Precision Medicines PT; shares down

Reuters
Oct 20
BUZZ-Wedbush lifts <a href="https://laohu8.com/S/PRAX">Praxis Precision Medicines</a> PT; shares down

** Wedbush lifts Praxis Precision Medicines PRAX.O PT to $73 from $33, representing a 60.5% downside on stock's last close, maintains "underperform" rating

** Brokerage says it lifts PT after reincorporating ulixacaltamide credit beginning in 2027 and layering in the offering

** Says co is ahead in Essential Tremor indication and the strengthened balance sheet offers additional flexibility to prepare

** However, brokerage says it remains cautious on the setup

** Shares of Praxis Precision Medicines fall nearly 2% to about $186 in premarket trading

** 13 of 14 brokerages rate the stock "buy" or higher and one strong sell; their median PT is $260.5 - data compiled by LSEG

** As of last close, shares up about 146.9% YTD

(Reporting by Parth Chandna)

((Parth.Chandna@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10